Table 1.
Patient | Gene | Nucleotide change | Protein change | Functional domain | In silico prediction tools | ||
---|---|---|---|---|---|---|---|
Mutation Taster | SIFT | Polyphen-2 | |||||
I | FGFR1 | c.320C>T | p.Ser107Leu | Ig-like C2-type 1 domain | Disease-causing | Tolerated | Benign |
II | F GFR1 | c.1342C>T | p.Arg448Trp | Juxta-membrane domain | Disease-causing | Affects protein function | Probably damaging |
III | FGFR1 | c.2314C>T | p.Pro772Ser | C-terminal tail | Disease-causing | Tolerated | Benign |
IV | FGFR1 | c.2314C>T | p.Pro772Ser | C-terminal tail | Disease-causing | Tolerated | Benign |
V | PROKR2 | c.253C>T | p.Arg85Cys | First intracellular loop | Disease-causing | Affects protein function | Probably damaging |
VI | PROKR2 | c.743G>A | p.Arg248Glu | Third intracellular loop | Polymorphism | Tolerated | Benign |